Refine by MP, party, committee, province, or result type.
Health committee I did not actually, but certainly the regulation of marketing activity is broader than just advertising. I think if you look at, for example, the natural health product regulations and the Food and Drugs Act, they do capture a broader range of potential activities than advertisin
December 2nd, 2014Committee meeting
Gerry Harrington
Health committee Absolutely.
December 2nd, 2014Committee meeting
Gerry Harrington
Health committee To your first question, the status quo right now is essentially an unregulated marketplace, so certainly the answer is yes. That's easily done. Your second question I think is a critical one. If e-cigarettes are regulated as a health product, we have standards and we have defini
December 2nd, 2014Committee meeting
Gerry Harrington
Health committee Yes, there are potential conflicts there. I understand the question. Certainly I don't have a concern over it. I think a health product company is a health product company. So natural health product medicine and we have the same objectives, the health of Canadians. Certainly I th
December 2nd, 2014Committee meeting
Gerry Harrington
Health committee Yes. At the most fundamental level, what we have right now because of the non-enforcement of the existing ban is essentially an unregulated market. On top of all the concerns we're discussing now on a policy level, there is the simple math about who is watching what goes into th
December 2nd, 2014Committee meeting
Gerry Harrington
Health committee Yes. I think advertising on a variety of levels is problematic. In the absence of an agreed-upon regulatory structure, the question arises about what claims can be made for these products—what you are advertising, what claims are being made, and what assurances are being given
December 2nd, 2014Committee meeting
Gerry Harrington
Health committee Thank you. Mr. Chair, members of the committee, thank you for giving me the opportunity to provide input into your study of e-cigarettes. My name is Gerry Harrington and I am the director of policy for Consumer Health Products Canada. Consumer Health Products Canada is the tr
December 2nd, 2014Committee meeting
Gerry Harrington
Health committee I think probably the best example of the most aggressive policy being pursued is in the United Kingdom. In 2000 the then Blair government issued a new ten-year plan for the National Health Service, which is roughly equivalent to what we loosely call medicare. In that blueprint, t
February 7th, 2012Committee meeting
Gerry Harrington
Health committee Thank you, David. Consumer health products have an important role to play in thoughtful health promotion and disease prevention strategies. OTC medicines and natural health products are vital elements in the toolbox Canadians have access to when they practise self-care and engag
February 7th, 2012Committee meeting
Gerry Harrington
Health committee A quick comment. I think you'll find that most industrial sectors are divided: there are companies that follow the law as a matter of course, and there are those that do not. The members of our association strongly believe that the more inspectors, the more enforcement staff th
June 2nd, 2009Committee meeting
Gerry Harrington
Health committee From the operative position of an industry regulated under the Food and Drugs Act and that is intended to be exempt from this bill, allow me to just provide an example from our world. Under the Food and Drugs Act, all products are assumed to have risks attached to them. If ther
June 2nd, 2009Committee meeting
Gerry Harrington
Health committee Yes.
June 2nd, 2009Committee meeting
Gerry Harrington
Health committee Thank you for your question, Mr. Dufour. Allow me to answer in English. The question of the release of confidential business information is a key one for an industry that is proprietary information-based, such as the consumer health products industry. We are in a bit of an aw
June 2nd, 2009Committee meeting
Gerry Harrington